Indeed, the strong correlation between the expression of PRAT and poor prognosis in patients with small cell lung cancer and the inhibition of non-anchored growth of SCLC cell lines by PRAT deficiency suggest that PRAT may be a promising therapeutic target for SCLC. Here, PPAT is linked to small cell lung carcinoma.